These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29140649)

  • 41. Medicare fraud: a federal priority. What is it and how to avoid it.
    Englander JR
    NAHAM Manage J; 1996; 23(2):8-10. PubMed ID: 10162047
    [No Abstract]   [Full Text] [Related]  

  • 42. Building Biased Jurors: Exposing the Circularity of the Inherent Bias Rationale for Felon-Juror Exclusion.
    Binnall JM; Petersen N
    Psychiatr Psychol Law; 2020; 27(1):110-125. PubMed ID: 32284783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defrauding AIDS patients: federal felony statute may be necessary to curb multiplying scams.
    Margolis RE
    Healthspan; 1993; 10(7):14-6. PubMed ID: 10132267
    [No Abstract]   [Full Text] [Related]  

  • 44. Percentage compensation arrangements: suspect, but not illegal.
    Fedor FP
    Healthc Financ Manage; 2001 Jan; 55(1):48-52. PubMed ID: 11211487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Criminal liability for misconduct in scientific research.
    Kuzma SM
    Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
    [No Abstract]   [Full Text] [Related]  

  • 46. Criminal actions. Hospital pleads guilty to wire fraud for medically unnecessary procedures. U.S. v. United Memorial Hospital, No. 1:01-CR-238 (W.D. Mich. Jan. 8, 2003).
    West JC
    J Healthc Risk Manag; 2003; 23(3):36-7. PubMed ID: 15842165
    [No Abstract]   [Full Text] [Related]  

  • 47. Fraud and abuse crackdown: do corporate compliance programs make a difference?
    Sledge SK; Harris K
    Ga Hosp Today; 1996 Jan; 40(1):3. PubMed ID: 10157296
    [No Abstract]   [Full Text] [Related]  

  • 48. Health care fraud and abuse: new weapons, new penalties, and new fears for providers created by the Health Insurance Portability and Accountability Act of 1996 ("HIPAA").
    Faddick CM
    Ann Health Law; 1997; 6():77-104. PubMed ID: 10173281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Policing quality. Federal prosecutors increasingly are looking to prosecute providers who defraud government programs via inadequate patient care.
    Taylor M
    Mod Healthc; 2003 Jun; 33(26):24-8, 34. PubMed ID: 12858640
    [No Abstract]   [Full Text] [Related]  

  • 50. Well-planned due diligence can protect buyers of healthcare entities.
    Doty LW; Campbell AT
    Healthc Financ Manage; 2000 Oct; 54(10):56-8. PubMed ID: 11183545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A summary of fraud and abuse issues affecting clinical research programs.
    Roberts CM
    QRC Advis; 1998 Oct; 14(12):9-12. PubMed ID: 10185022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medicare and state health care programs: fraud and abuse, civil money penalties and intermediate sanctions for certain violations by health maintenance organizations and competitive medical plans--HHS. Final rule.
    Fed Regist; 1994 Jul; 59(135):36072-87. PubMed ID: 10136015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whistleblowers' wings clipped by Fifth Circuit.
    Silverman SI
    Contemp Longterm Care; 2000 Jan; 23(1):47. PubMed ID: 10977699
    [No Abstract]   [Full Text] [Related]  

  • 55. Health care providers and fraud investigations: what can you do when the government changes the rules in the middle of the game?
    Rountree GE
    Ann Health Law; 1999; 8():97-128. PubMed ID: 10622909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, Inc.
    Wartman GJ
    Food Drug Law J; 2009; 64(2):291-311. PubMed ID: 19999286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. OIG offers new information on Medicare/Medicaid anti-kickback law.
    Roeder KH; Sledge SK
    Ga Hosp Today; 1997 Feb; 41(2):3. PubMed ID: 10167205
    [No Abstract]   [Full Text] [Related]  

  • 58. Physician financial relationships in the new regulatory environment.
    Roberts RD
    Physician Exec; 1994 Nov; 20(11):50-2. PubMed ID: 10140898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guide to preemption of state-law claims against Class III PMA medical devices.
    Whitney DW
    Food Drug Law J; 2010; 65(1):113-39, ii-iii. PubMed ID: 24475536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anatomy of a fraud indictment and acquittal.
    Cobuzzi BJ
    J Med Pract Manage; 2009; 24(4):237-40. PubMed ID: 19288648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.